Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

VIRAMUNE XR

BOEHRINGER INGELHEIM (CANADA) LTD LTEE

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is VIRAMUNE XR discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that VIRAMUNE XR 400MG has been permanently discontinued (last updated August 21, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is VIRAMUNE XR not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file4 products
Affected strength400MG
Last updated2019-08-21

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

JAMP NEVIRAPINE

JAMP PHARMA CORPORATION

200MG · DIN 02405776

Different strengthDifferent dosage formSame routeNo current shortage

TEVA-NEVIRAPINE

TEVA CANADA LIMITED

200MG · DIN 02352893

Different strengthDifferent dosage formSame routeNo current shortage

AURO-NEVIRAPINE

AURO PHARMA INC

200MG · DIN 02318601

Different strengthDifferent dosage formSame routeNo current shortage

APO-NEVIRAPINE

APOTEX INC

200MG · DIN 02396653

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02367289

Strength

400MG

Dosage Form

TABLET (EXTENDED-RELEASE)

Route

ORAL

Active Ingredient

NEVIRAPINE

Tier

Unrated

Last Updated

2019-08-21

Reason for Shortage

Business reasons

Other Products from BOEHRINGER INGELHEIM (CANADA) LTD LTEE

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.